Skip to content
value.today

QurAlis Corp

🇺🇸 Cambridge, Massachusetts, USAPharmaceuticalsFounded 2016
Total raised
$118 M
4 rounds on record
Latest round
$20 M
Aug 2025
First round on record
May 2020
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of QurAlis Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2025$20 MNo. 4$10 to $50 million

QurAlis Corp: Raise no. 4, Aug 2025

Investors in this round

19 investors had bought by the notice of Sep 5, 2025: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $25 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, other: Convertible Promissory Notes
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jason C.D. Brown · Executive Officer · Mr. Brown is the Chief Financial Officer of the Issuer.
  • Kasper C.D. Roet · Director, Executive Officer, Promoter · Mr. Roet is the Chief Executive Officer, President, Secretary and Treasurer of the Issuer.
  • Kasper C.D. Roet · Director, Executive Officer, Promoter · Mr. Roet is the Chief Executive Officer, President and Treasurer of the Issuer.
  • Shafique C.D. Virani · Executive Officer
  • Amy C.D. Schulman · Director
  • Anne C.D. Whitaker · Director
  • Cillian C.D. King · Director
  • Johannes C.D. Fruehauf · Director
  • Laia C.D. Crespo-Martin · Director
  • Luc C.D. Dochez · Director
  • Michael C.D. Hutton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kasper Roet, Chief Executive Officer of the Issuer. Source: SEC Form D, newest notice filed Sep 5, 2025. Read the notice at the SEC.

debt, optionsSEC
Dec 2022$60 MNo. 3$50 to $250 million

QurAlis Corp: Raise no. 3, Dec 2022

Investors in this round

27 investors had bought by the notice of Mar 13, 2023: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$60 M of $88 M offered; $28 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Shares of Series B-1, B-2 and B-3 Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Angela C.D. Genge · Executive Officer · Dr. Genge is the Chief Medical Officer of the Issuer.
  • Chris C.D. Thomajan · Executive Officer · Mr. Thomajan is the Chief Financial Officer of the Issuer.
  • Daniel C.D. Elbaum · Executive Officer · Mr. Elbaum is the Chief Scientific Officer of the Issuer.
  • Hagen C.D. Cramer · Executive Officer · Mr. Cramer is the Chief Production Officer of the Issuer.
  • Julio E. Vega · Executive Officer · Mr. Vega is the Secretary of the Issuer
  • Kasper C.D. Roet · Director, Executive Officer, Promoter · Mr. Roet is the Chief Executive Officer, President and Treasurer of the Issuer.
  • Vikas C.D. Sharma · Executive Officer · Mr. Sharma is the Chief Business Officer of the Issuer.
  • Amy C.D. Schulman · Director
  • Anne C.D. Whitaker · Director
  • Cillian C.D. King · Director
  • Johannes C.D. Fruehauf · Director
  • Laia C.D. Crespo-Martin · Director
  • Luc C.D. Dochez · Director
  • Michael C.D. Hutton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kasper Roet, Chief Executive Officer of the Issuer. Source: SEC Form D, newest notice filed Mar 13, 2023. Read the notice at the SEC.

equitySEC
Aug 2022$5 MNo. 2$2 to $10 million

QurAlis Corp: Raise no. 2, Aug 2022

Investors in this round

19 investors had bought by the notice of Sep 1, 2022: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $10 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, other: Convertible Promissory Notes
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Angela C.D. Genge · Executive Officer · Dr. Genge is the Chief Medical Officer of the Issuer.
  • Chris C.D. Thomajan · Executive Officer · Mr. Thomajan is the Chief Financial Officer of the Issuer.
  • Daniel C.D. Elbaum · Executive Officer · Mr. Elbaum is the Chief Scientific Officer of the Issuer.
  • Hagen C.D. Cramer · Executive Officer · Mr. Cramer is the Chief Production Officer of the Issuer.
  • Kasper C.D. Roet · Director, Executive Officer, Promoter · Mr. Roet is the Chief Executive Officer, President, Secretary and Treasurer of the Issuer.
  • Vikas C.D. Sharma · Executive Officer · Mr. Sharma is the Chief Business Officer of the Issuer.
  • Amy C.D. Schulman · Director
  • Anne C.D. Whitaker · Director
  • Johannes C.D. Fruehauf · Director
  • Jonathan C.D. Behr · Director
  • Luc C.D. Dochez · Director
  • Michael C.D. Hutton · Director
  • Roel C.D. Bulthuis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kasper Roet, Chief Executive Officer of the Issuer. Source: SEC Form D, newest notice filed Sep 1, 2022. Read the notice at the SEC.

debt, optionsSEC
May 2020$33 MNo. 1$10 to $50 million

QurAlis Corp: Raise no. 1, May 2020

Investors in this round

25 investors had bought by the notice of May 18, 2020: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$33 M of $60 M offered; $27 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series A-1 Preferred Stock and Series A-2 Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris C.D. Thomajan · Executive Officer · Mr. Thomajan is the Chief Financial Officer of the Issuer.
  • Daniel C.D. Elbaum · Executive Officer · Mr. Elbaum is the Chief Scientific Officer of the Issuer.
  • Kasper C.D. Roet · Director, Executive Officer, Promoter · Mr. Roet is the Chief Executive Office of the Issuer.
  • Amy C.D. Schulman · Director
  • Johannes C.D. Fruehauf · Director
  • Jonathan C.D. Behr · Director
  • Jonathan C.D. Fleming · Director
  • Luc C.D. Dochez · Director
  • Roel C.D. Bulthuis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kasper C.D. Roet, Chief Executive Officer of the Issuer. Source: SEC Form D, newest notice filed May 18, 2020. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • QurAlis Corp chose not to state its revenue in its newest notice of a funding round (Sep 2025).

    SEC Form D · Sep 2025

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Sep 2025

That is all the official record says: QurAlis Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of QurAlis Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 27 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by QurAlis Corp
NameRoleNamed in
Jason C.D. BrownMr. Brown is the Chief Financial Officer of the Issuer.Sep 2025
Kasper C.D. RoetMr. Roet is the Chief Executive Officer, President, Secretary and Treasurer of the Issuer.Sep 2025
Shafique C.D. ViraniExecutive officerSep 2025
Angela C.D. GengeDr. Genge is the Chief Medical Officer of the Issuer.Mar 2023
Chris C.D. ThomajanMr. Thomajan is the Chief Financial Officer of the Issuer.Mar 2023
Daniel C.D. ElbaumMr. Elbaum is the Chief Scientific Officer of the Issuer.Mar 2023
Hagen C.D. CramerMr. Cramer is the Chief Production Officer of the Issuer.Mar 2023
Julio E. VegaMr. Vega is the Secretary of the IssuerMar 2023
Vikas C.D. SharmaMr. Sharma is the Chief Business Officer of the Issuer.Mar 2023
Amy C.D. SchulmanDirectorSep 2025
Anne C.D. WhitakerDirectorSep 2025
Cillian C.D. KingDirectorSep 2025
Johannes C.D. FruehaufDirectorSep 2025
Kasper C.D. RoetMr. Roet is the Chief Executive Officer, President, Secretary and Treasurer of the Issuer.Sep 2025
Laia C.D. Crespo-MartinDirectorSep 2025
Luc C.D. DochezDirectorSep 2025
Michael C.D. HuttonDirectorSep 2025
Jonathan C.D. BehrDirectorSep 2022
Roel C.D. BulthuisDirectorSep 2022
Jonathan C.D. FlemingDirectorMay 2020
Kasper C.D. RoetMr. Roet is the Chief Executive Officer, President, Secretary and Treasurer of the Issuer.Sep 2025